National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 75294 [2023-24139]
Download as PDF
<![CDATA[
75294
Federal Register / Vol. 88, No. 211 / Thursday, November 2, 2023 / Notices
BILLING CODE 4151–17–P
Contact Person: Michael W. Krause, Ph.D.,
Scientific Director, NIDDK, National Institute
of Diabetes and Digestive and Kidney
Diseases, National Institute of Health,
Building 5, Room B104, Bethesda, MD
20892–1818, (301) 402–4633, mwkrause@
helix.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 27, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Last name
WENDEL ...................
WESLEY ...................
WILLIAMS .................
WILLIAMS .................
WULFF ......................
YARBOROUGH ........
First name
JENNIFER.
KENYATA.
CARLIS.
RASHEED.
KATHARINE.
LA MONTE.
Michelle Monroe,
Director, Executive Resources.
[FR Doc. 2023–24207 Filed 11–1–23; 8:45 am]
[FR Doc. 2023–24139 Filed 11–1–23; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIDDK.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual grant
applications conducted by the National
Institute of Diabetes and Digestive and
Kidney Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: April 19–20, 2024.
Open: April 19, 2024, 10:00 a.m. to 10:20
a.m.
Agenda: Introductions and Overview.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Closed: April 19, 2024, 10:30 a.m. to 5:00
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual Investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
VerDate Sep<11>2014
16:32 Nov 01, 2023
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Molecular
and Cellular Analysis Technologies.
Date: December 14–15, 2023.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W608, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Survivorship Needs of Individuals Living
with Advanced Cancer (R01).
Date: January 11, 2024.
Time: 9:00 a.m. to 6:00 p.m.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W108, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; IMAT
Biospecimen Research.
Date: January 11, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Technologies for Cancer Research.
Date: January 25–26, 2024.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W608, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Transition Career Development Award and
Institutional Research Training and
Education Grants.
Date: January 25, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W234, Rockville, Maryland 20850,
240–276–6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review SEP–II.
Date: February 1–2, 2024.
Time: 9:30 a.m. to 5:30 p.m.
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 88, Number 211 (Thursday, November 2, 2023)]
[Notices]
[Page 75294]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24139]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, NIDDK.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and
evaluation of individual grant applications conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: April 19-20, 2024.
Open: April 19, 2024, 10:00 a.m. to 10:20 a.m.
Agenda: Introductions and Overview.
Place: National Institutes of Health, Building 10, 10 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Closed: April 19, 2024, 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual Investigators.
Place: National Institutes of Health, Building 10, 10 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael W. Krause, Ph.D., Scientific Director,
NIDDK, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institute of Health, Building 5, Room B104,
Bethesda, MD 20892-1818, (301) 402-4633, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: October 27, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-24139 Filed 11-1-23; 8:45 am]
BILLING CODE 4140-01-P
